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DUNN, P. CAROLYN, Ph.D. Effects of n-3 PUFA and n-6 PUFA on Plasma 
Lipids, Bleeding Time, Prothrombin Time, and Liver Cholesterol in the 
Gerbil. (1988) 
Directed by Dr. Karen L. Graves. 62 pp. 
This dissertation research assessed the effects of n-3 and n-6 
PUFA fed in varying combinations on plasma lipids, bleeding time, 
prothrombin time, and liver cholesterol in 90 adult male gerbils. 
Gerbils (15 per group) were randomly assigned to one of six dietary 
treatments. The dietary treatments differed only in type of fat fed. 
All diets contained 15% fat by weight (14% as the test fat and 1 % as 
safflower oil). Group 1 consumed 100% of their test fat as lard 
(SFA), group 2 100% as safflower oil (n-6 PUFA), group 3 100% as 
MaxEPA oil (n-3 PUFA), group 4 25% n-3 PUFA and 75% n-6 PUFA, group 5 
25% n-6 PUFA and 75% n-3 PUFA, and group 6 50% n-6 PUFA and 50% n-3 
PUFA. The gerbils remained on the test diets for five weeks. 
Plasma lipids measured in the study included alpha (HDL-C), 
beta (LDL-C and VLDLC), total cholesterol, and triglycerides. The 
only statistically significant effect of dietary treatment on any 
plasma lipid measure was for triglycerides. The gerbils consuming the 
100% n-6 PUFA containing diet exhibited the highest mean triglyceride 
level. This was significantly different (jd <. .05) from mean levels 
exhibited by those animals consuming the 50% n-6 PUFA 50% n-3 PUFA 
and 25% n-6 PUFA 75% n-3 PUFA containing diets. No significant 
overall effects of the dietary treatments were observed for bleeding 
time, prothrombin time, or liver cholesterol. 
TABLE OF CONTENTS 
Page 
APPROVAL PAGE 1i 
ACKNOWLEDGMENTS iii 
LIST OF TABLES vii 
LIST OF FIGURES viii 
CHAPTER 
I. INTRODUCTION 1 
Objectives of the Study 3 
Hypotheses 4 
II. REVIEW OF LITERATURE 5 
Plasma Lipids 5 
Bleeding Time arid Prothrombin Time 14 
Liver Cholesterol 18 
Ratio of n-6 to n-3 PUFA 20 
III. METHODOLOGY 21 
Study Design 21 
Animals 22 
Diets 22 
Blood and Tissue Collection 24 
Plasma Lipid Analysis 25 
Bleeding Time and Prothrombin Time 25 
Liver Cholesterol 25 
Statistical Analysis 26 
IV. RESULTS AND DISCUSSION 27 
Weight Gain 27 
Plasma Lipids 30 
Bleeding Time and Prothrombin Time 38 
Liver Cholesterol 41 
Concluding Comments 43 
Hypothesis Tests 44 
V. RECOMMENDATIONS FOR FUTURE RESEARCH 46 
v  
Page 
BIBLIOGRAPHY 49 
APPENDICES 
Appendix A. Composition of American Institute of Nutrition 
Vitamin and Mineral Mix 56 
Appendix B. Raw Data 59 
v i  
LIST OF TABLES 
Table Page 
1 Animal Feeding Trials: Summary of Effects of Marine 
Oil or n-3 Polyunsaturated Fatty Acid on Plasma Lipid 
Parameters 6 
2 Human Feeding Trials: Summary of Marine Oil or n-3 
Polyunsaturated Fatty Acid on Plasma Lipid Parameters. ... 7 
3 Content of Omega-3 Fatty Acids and Other Fat Components 
of Selected Seafood Products 8 
4 Dietary Treatments 22 
5 Diet Composition - Recorded as Percent by Weight 23 
6 Means and Standard Deviations for Beginning Weight, 
Ending Weight, and Weight Change for Each Dietary 
Treatment 28 
7 Least Square Means for Triglycerides, Total Cholesterol, 
Alpha and Beta Cholesterol, and Alpha to Total 
Cholesterol Ratio for Each Dietary Treatment, Covaried 
for Weight Change. . 31 
8 Least Square Means for Bleeding Time and Prothrombin 
Time for Each Dietary Treatment, Covaried for Weight 
Change 39 
9 Least Square Means for Liver Cholesterol for Each 
Dietary Treatment, Covaried for Weight Change 42 
« • 
vn 
LIST OF FIGURES 
Figure Page 
1 Roles of Linoleic Acid and Arachidonic Acid in 
Prostaglandin Synthesis 15 
viif 
1  
CHAPTER I 
INTRODUCTION 
Modification of risk factors is the major clinical and public 
health approach to the prevention of coronary heart disease (CHD). 
Scientific evidence implicates high levels of blood cholesterol as a 
major risk factor for CHD which has been observed in epidemiological, 
genetic, clinical, metabolic, experimental, pathological, and inter­
vention studies. Animal, metabolic, and clinical studies have all 
shown that it is possible to favorably alter plasma cholesterol levels 
by dietary means. Recently, attention has focused on the possible 
beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFA) 
in reduction of incidence of CHD. 
Several epidemiological based comparison studies between 
Eskimos of Greenland and those residing in Denmark were conducted in 
the 1970s (Bang & Dyerberg, 1972; Band & Dyerberg, 1980; Bang, 
Dyerberg, & Nielson, 1971; Dyerberg, Bang, & Hjorne, 1975). These 
studies noted that the Greenland Eskimos had lower serum triglycer­
ides, lower very low density lipoprotein cholesterol (VLDL-C), lower 
low density lipoprotein cholesterol (LDL-C), and higher high density 
lipoprotein cholesterol (HDL-C). Eskimos living in Greenland also 
exhibited prolonged bleeding times and a lower incidence of CHD than 
those residing in Denmark. 
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The diets of the Greenlanders and Danes also differed. The 
Greenland Eskomos consumed nearly 454 gm (1 lb) of fish per day, while 
the Danish Eskimos consumed less than 20 gm (< 1 oz.) of fish per 
day. Both fat and cholesterol content were higher in the Greenlanders1 
diet; these increases were contributed by whale blubber and other 
marine fats. 
The amount of fat actually consumed by populations with high 
fish consumption is similar to the fat content of a more Western diet. 
However, the fat composition of the high fish diets is low in satu­
rated fatty acids (SFA) and consists primarily of unsaturated fatty 
acids. These unsaturated fatty acids differ from the PUFAs consumed in 
the typical Western diet. Those unsaturated fats are derived primarily 
from plant sources, and the desaturation occurs at the sixth position 
(n-6 PUFA) from the terminal methyl group, whereas, marine oils are 
desaturated at the third position (n-3 PUFA). The primary n-3 PUFA 
found in marine oils are eicosapentaenoic acid (EPA) (C 20:5) and 
decosahexaenoic acid (DHA) (C 22:6). These two PUFAs, EPA more so 
than DHA, are found in large amounts in the Eskimos' diet. Linoleic 
acid (LA) C 18:2), an n-6 PUFA, is the predominant PUFA in the typical 
Western diet. It is these differences (i.e., abundance of n-3 PUFA 
and lower SFA consumption) that are apparently the dietary factors 
related to the Eskimos' relative freedom from CHD. 
The n-3 PUFA rich diets appear to have two biological effects 
which impact on the incidence of CHD. They lower plasma lipids and 
reduce platelet adhesiveness (i.e., increase bleeding time). However, 
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it appears that unless n-3 PUFAs are fed at high levels, they do not 
exert much of a hypocholesterolemic effect. Omega-6 PUFAs are known 
to be powerful hypolipidemic agents, but their effect on platelet 
aggregation is not as pronounced as that seen with feeding n-3 PUFAs 
(Keys, Anderson, & Grande, 1957). 
The present study was designed to examine the effects of n-3 
PUFA when fed in combination with n-6 PUFA on plasma lipids and plate­
let function as measured by bleeding time and prothrombin time. 
Several combinations of the two PUFA types were fed, and one objective 
of the study was to determine combinations that optimize the lipid 
lowering effect while at the same time did not compromise the bene­
ficial platelet function effect. Measurement of liver cholesterol was 
measured to provide insight into the mechanism of action of combination 
of n-3 and n-6 PUFA on synthesis and storage of hepatic cholesterol. 
Objectives of the Study 
The specific objectives of the study were as follows: 
1. To assess the effect of differing levels of n-3 and n-6 
PUFAs fed in combination on plasma lipids, bleeding time, 
prothrombin time, and liver cholesterol. 
2. To assess the effect of n-3 PUFA, n-6 PUFA, and SFA on 
plasma lipids, bleeding time, prothrombin time, and liver 
cholesterol. Observations from these three groups will 
serve as reference or comparison values. 
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3. To determine combinations of the n-3 and n-6 PUFAs that 
optimize the hypolipidemic effect without compromising the 
beneficial reduction in platelet adhesiveness. 
4. To determine the usefulness of the gerbil as a model in 
the study of diet and CHD risk factors. 
Hypotheses 
The hypotheses to be tested are as follows: 
H-|: There will be no significant difference in plasma tri­
glycerides across the six dietary treatments. 
H2: There will be no significant difference in total choles­
terol across the six dietary treatments. 
Hg: There will be no significant difference in HDL cholesterol 
across the six dietary treatments. 
H^: There will be no significant difference in LDL and VLDL 
cholesterol across the six dietary treatments. 
H^: There will be no significant difference in bleeding time 
across the six dietary treatments. 
Hg: There will be no significant difference in prothrombin 
time across the six dietary treatments. 
H^: There will be no significant difference in liver choles­
terol across the six dietary treatments. 
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CHAPTER II 
REVIEW OF LITERATURE 
Studies presently indicate two important actions of n-3 PUFAs, 
decrease in plasma lipids and a beneficial change in platelet func­
tion. Few studies, however, have seen a lipid lowering effect, with 
the exception of plasma triglycerides, when n-3 PUFAs were fed in 
amounts feasible for consumption by the American population. On the 
other hand, even low levels of n-3 PUFAs were observed to influence 
platelet function as measured by bleeding time. This review will 
firstly examine the effects of n-3 PUFA feeding on plasma lipids; 
secondly, their effect on bleeding time and prothrombin time, indi­
cators of platelet function; and lastly, the effect of differing 
ratios of n-6 to n-3 dietary PUFA. 
Plasma Lipids 
Published reports of observations on the Greenland Eskimos 
prompted many subsequent studies in both humans and various animal 
models. The results are summarized, with respect to plasma lipid 
profiles, in Table 1 (animal feeding trials) and Table 2 (human feed­
ing trials). Omega-3 PUFA concentrations of fish oils and fatty fish 
fed in the studies reviewed are presented in Table 3. 
Animal studies. The effects of n-3 PUFA on plasma lipids have 
been investigated in several animal models. Due in part to differing 
Table 1 
Animal Feeding Trials: Summary of Effects of Marine Oil or H-3 Polyunsaturated Fatty Acid on Plasma Lipid Parameters 
Reference Diets: Compared to 
Duration 
of Diet T5~ Cholesterol 
mq/100 ml 
HOL-C TOUT VlOl-C 
I. Rats 
Kobatake et al. (1983) 
Wong et al. (1984) 
Horisakl et al. (1983) 
Haug et al. (1987) 
II. Rabbits 
VasDias et al. (1982) 
III. Pigs 
Ruiter et al. (1978) 
Hartog et al. (1987) 
Hartog et al. (1987) 
IV. Dogs 
Culp et al. (1980) 
St squid Hver oil 
IS Mt X HaxEPA 
100 mg EPAj/day 
100 mg EPAjyday 
100 mg OHA /day 
21X energy as lard 
211 energy as fish 
oil 
42X energy as fish 
oil 
before consump­
tion of 60 gm/Kg 
HaxEPA oil 
101 mackerel oil 
9.1. wt X mackerel 
oil 
4.5 wt X mackerel 
oil 
4.5 wt t lard 
25X energy as 
menhaden oil 
5t lard 
15 wt X saf-
flower oil 
basal diet 
basal diet 
42X energy 
as lard 
after consump­
tion of HaxEPA 
oil 
101 olive oil 
9.1 wt X lard 
9 wt X lard 
2 weeks 
2 weeks 
2 weeks 
2 weeks 
4 weeks 
60 days 
4 weeks 
8 weeks 
16 weeks 
Standard chow 36-45 days 
+40X 
NSO 
NSD 
is1gf 
isig 
NSD 
*44X 
16.2X 
Isig 
NSD 
iC43X 
NSD* 
NSO 
NSO 
NSD 
NSO 
J41X 
•tsig 
••b109X 
NSD 
•lit 
NSD 
NSD 
J-47X 
NSO 
NSD 
NSD 
•slg 
Jslg 
4> 35X 
aNS0 * no significant difference (|> £ 0.05) between comparison times 
^ * significant increase between comparison times 
c • significant decrease between comparison times 
dEPA • elcosapentaenolc acid 
e0HA * docosahexaenoic acid 
%ig • significant difference (£4 0.05) between comparison times 
Title 2 
Human Feeding Trials: Suonary of Effects of Marine 011 or NO Polyunsaturated fatty Acid on Plasma Lipid Parameters 
Reference Diets: Coopered to 
Duration 
of Olet 
wo/100 ml 
16 Cholesterol HOL-C 101-t VIN.-C 
I. Fatty Fish 
von Lossonczy et el. 
(1978) 
Singer et al. <1983) 
Phllllpson et al. (1965) 
Goodnight et al. (1981) 
Harris et el. (1983) 
Fehlly et el. (1983) 
H. Cod Liver 011 (CLO) 
Sanders et al. (1981) 
Bronsgeest et al. (1981) 
Ut. MaxEPA 011 
Nestel et al. (1984) 
Sanders et el. (1983) 
Sanders et al. (1983) 
Saynor et al. (1984) 
ISO ga cheese 
280 ga herring 
control diet 
control diet 
control diet 
usual diet 
before 
supplementation 
before 
supplementation 
before 
supplementation 
200 gm mackerel 
280 ga mackerel 
salmon and 
salmon oil 
1 lb selmon/day A 
60-90 ml MaxEPA 
Oil/day 
1 lb selmon/day i 
3-6 I MaxEPA oil/ 
day 
317 g» fatty 
fltViMk (uirigi) 
after supplementa­
tion of 20 ml CLO 
after supplementa­
tion 
1.4 gm w-3 FA 
2.3 gm w-3 FA 
4.1 gm w-3 FA 
8.2 gm w-3 FA 
after supplementa­
tion Mith 30f 
energy as MaxEPA oil 
10 <m olive I 
com oil 
(crossover) 
20 ml Unseed 
before 
supplementation 
10 ga MaxEPA oil 
i MaxEPA oil 
3 weeks 
2 weeks 
4 weeks 
4 weeks 
4 weeks 
3 months 
$ weeks 
4 weeks 
4 weeks 
2 weeks 
2 weeks 
before 
supplementation 
111Ingworth et al. (1984) control diet 
S gm/day MaxEPA oil 3 weeks 
10 gm/day MaxEPA oil 
20 ga/day Max EPA oil 
20 ml MaxEPA oil 1 awntJi 
6 months 
12 months 
24 months 
120 ga salmon oil 4 weeks 
'"SO • no significant difference (£4 0.05) between comparison times 
• significant increase between comparison times 
c • significant decrease between comparison times 
4*38* 1*7* 
(females only) 
NSO* \ *ii 
Typ* lib hyp«r11pt<l«aU 4,641 ^271 ^171 
Type V hyperlipldemle 
^79* ^481 HSO 
4. 
4,38* 
4" 
V 
4r 
.̂ 14* *23* 
*J2* 
1.371 
*37* 
4.411 
4^31 
•V>« 
USD 
NSO 
HSO 
NSO 
HSO 
•Vn 
NSD 
A 4 *  
iso 
4.1 SI 
^23* 
NSO 
USD 
NSO 
NSD 
T3IX 
* 10% •̂10* 
NSD 
T14* 
NSO 
12* 
481 
^16* 
NSO 
^201 
^73* 
^ 711 
4 381 
NSO NSO NSO NSD NSD 
NSO NSO NSO NSO NSD 
NSO NSO NSO NSO NSO 
vn NSO NSO NSO 4 
4/ 4, 
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Table 3 
Content of Omega-3 Fatty Acids and Other Fat Components of Selected 
Seafood Products (100 gm edible portion, raw) (Hepburn, Exler, & 
Weihrauch, 1986) 
Food Item 
Total 
Fat 
Total 
SFA 
Total 
MUFA 
Total 
PUFA 18:3a 20:5b 22:6C 
qm 
Mackerel, king 13.0 2.5 5.9 3.2 - 1.0 1.2 
Salmon, chinook 10.4 2.5 4.5 2.1 0.1 0.8 0.6 
Cod lever oil 100.0 17.6 51.2 25.8 0.7 9.0 9.5 
Menhaden oil 100.0 33.6 32.5 29.5 1.1 12.7 7.9 
MaxEPA oil 100.0 25.4 28.3 41.1 - 17.8 11.6 
Salmon oil 100.0 23.8 39.7 29.9 1.0 8.8 11.1 
a «C Linolenic Acid 
^Eicosapentaenoic Acid 
cDocosahexaenoic Acid 
species, variability in diet composition, and duration of the studies, 
there are some contradictions in results. 
Rats have been the most frequently employed model for the study 
of the effect of n-3 PUFA (see Table 1) (Huag & Hostmark, 1987; 
Kobatake, Hirahara, Innami, & Nishiole, 1983; Morisaki, Shinomiya, 
Matsuoka, Saito, & Kumagai, 1983; Wong, Nestel, Trimble, Storere, 
Illman, & Topping, 1984). Wong et al. (1984) observed a significant 
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decrease in triglycerides of those rats fed MaxEPA oil (15% by wt.). 
Triglycerides and VLDL-C were significantly decreased in rats fed 20% 
by wt. fish oil and in rats fed a combination of 20% by wt. fish oil 
and 20% by wt. lard as compared to rats fed a diet containing 20% by 
wt. lard (Haug, 1987). Kobatake et al. (1983) observed a decrease in 
total cholesterol only in those rats fed 5% by wt. squid liver oil as 
compared to 5% by wt. lard. High density lipoprotein cholesterol was 
also altered (109% increase) in those animals consuming the 5% squid 
oil. Morisake et al. (1983) also saw an increase in HDL-C but only 
when pure DHA was fed (100 mg/day), suggesting that HDL-C levels may 
be more sensitive to DHA than EPA intake. Morisake et al. observed 
no significant change in triglycerides, total cholesterol, LDL-C, or 
VLDL-C in those rats fed either DHA or EPA. In those rat studies 
that measured LDL no significant results of feeding n-3 PUFAs was 
observed. 
Several studies have been conducted using other mammalian 
species and have observed no notable effects of marine oils. New 
Zealand rabbits were fed 60 gm/Kg (6% by wts.) MaxEPA pi 1 and com­
parisons made before and after supplementation had no effect on 
plasma lipids (VasDias, Gibney, & Taylor, 1982). A study employing 
the dog also observed no effect on plasma lipids after feeding n-3 
PUFA (12% by wt.) (Culp, Lands, Luches, Pitt, & Romson, 1980). 
The pig has been used to model CHD pathogenecity; physiologi­
cally, it closely resembles humans. A significant decrease in 
triglycerides was observed by Ruiter, Jongblood, van Gent, Danse, & 
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Metz (1978) when pigs were fed 10% by wt. mackerel oil as compared to 
10% by wt. olive oil. However, no significant change in total choles­
terol was observed. The fatty acids in olive oil were predominantly 
monounsaturated and these were demonstrated to be hypocholestrolemic 
in nature (Keys et al., 1957). 
A significant decrease in triglycerides, total cholesterol, and 
HDL-C occurred when pigs were fed 9.1% by wt. mackerel oil as compared 
to 9.1% by wt. lard (Hartog, Lamers, Montfoort, Becker, Klompe, Morse, 
ten Cate, van der Werf, Hulsmann, Hugenholtz, & Verdouw, 1987). When 
pigs were fed a more moderate amount of mackerel oil (combination of 
4.5% by wt. mackerel oil and 4.5% by wt. lard compared to 9% by wt. 
lard), triglycerides and total cholesterol were still significantly 
decreased while there was no change in HDL-C (Hartog, Verdouw, 
Klompe, & Lamers, 1987). These studies by Hartog et al. (1987) 
suggest that feeding moderate amount of mackerel oil may have bene­
ficial effects on total cholesterol and triglycerides while maintain­
ing HDL-C levels. 
The present research employed the gerbil as the model. To date 
there are no published research articles on the effects of n-3 PUFA 
on plasma lipids in the gerbil. Gerbils have been demonstrated to be 
appropriate models in the study of diet-induced hyperlipidemia 
(Otken & Scott, 1984). Gerbils, like rats, carry the majority of 
their cholesterol in the HDL-C fraction. However, when challenged 
with a small amount of cholesterol (i.e., 0.1%) the majority of 
plasma cholesterol is carried in the LDL-C fraction similar to humans. 
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Also, increases in plasma cholesterol associated with dietary changes 
occur in the LDL-C fraction (Hegsted & Gallagher, 1967). A problem 
inherent in using the gerbil as a model is their small size. Blood 
collection is minimal, thus limiting measurable parameters. 
In summary, the animal studies reviewed show conflicting 
results. 0mega-3s appear to have more of an effect on triglycerides 
than other lipid parameters but results are inconsistent. These dis­
crepancies are due in part to differences in species, amount of fat 
fed, and the type of fat fed in the comparison group (i.e., PUFA or 
SFA). 
Human studies. There have been many studies conducted using 
both normo- and hyperlipidemic human subjects (see Table 2). As was 
true with the animal studies, the human feeding trials sometimes 
yielded inconsistent results, especially for total cholesterol levels. 
This lack of consistency may be partially attributed to differences in 
methodology, duration of the study period, variability in diet compo­
sition, and preexperimental serum cholesterol levels of the subjects. 
The present review is organized by type of test ingredient (i.e., 
fatty fish, cod liver oil, or MaxEPA oil). 
Several studies have fed fatty fish as the n-3 PUFA source. 
Triglycerides and VLDL-C were the plasma lipids most sensitive to n-3 
PUFA consumption. Even feeding levels as low as an average of 317 gm 
of fatty fish per week was associated with a slight decrease (6%) in 
plasma triglycerides (Fehily, Phillips, & Deadman, 1983). Feeding 
higher levels to both normo- and hypocholesterolemics produced even 
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greater reductions in plasma triglycerides (Harris, Connor, & McMurry, 
1983; Phillipson, Rothrock, Connor, Harris, & Illingsworth, 1985; 
Singer, Jager, Wirth, Voight, Nauman, Zimonthkowski, Hajdu, & 
Goedicke, 1983; von Lossonczy, Ruiter, Bronsgust-Schoute, van Gent, & 
Hermus, 1978). Very low density lipoprotein cholesterol levels were 
reduced significantly when at least 200 gm/day (6 oz.) of fatty fish 
were fed (Harris et al., 1983; von Lossenczy et al., 1978). Total 
cholesterol levels were also reduced significantly when at least 
200 gm of fatty fish were fed per day (von Lossenczy et al., 1978); 
however, when low levels of fatty fish were fed (317 gm/week) total 
cholesterol was not significantly reduced (Fehily et al., 1983). 
The response of HDL-C and LDL-C to fatty fish feeding is more 
variable. High density lipoprotein cholesterol levels were increased 
slightly in females in one study (von Lossonczy et al., 1978), 
decreased in Type lib hyperlipi demies (Phillipson et al., 1985), and 
were unchanged in all others. A decrease in LDL-C was observed in 
only two studies, one with hyperlipidemic patients fed salmon (amount 
not reported) (Phillipson et al., 1985), and when Harris et al. (1983) 
fed very large amounts of salmon and MaxEPA oil (1 lb. and 3-6 T/day, 
respectively). 
Cod liver oil, a relatively rich source of n-3 PUFA, has been 
fed as a supplement in two human feeding trials. Sanders, Vickers, 
and Hains (1981) observed significant decreases in triglycerides and 
increases in HDL-C with daily supplementation of 20 ml of the oil. 
Brongeest-Schoute, van Gent, Cuten, and Ruiter (1981) supplemented cod 
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liver oil in varying amounts to provide between 1.4 and 8.2 gm of n-3 
PUFA/day. No significant changes in total cholesterol, HDL-C, or 
LDL-C were reported. Triglycerides and VLDL-C levels were decreased, 
but only when the highest dosage was given. 
MaxEPA oil, a man-made oil rich in EPA, has also been used in 
human studies. Studies feeding levels from 5 gm/day to 30% energy 
(approximately 66 gms) from MaxEPA oil have observed a significant 
decrease in triglycerides (Illingsworth, Harris, & Connor, 1984; 
Nester, Connor, Reardon, Connor, Wong, & Boston, 1984; Sanders & 
Hochlano, 1983; Sanders & Roshani, 1983; Saynor, Verel, & Gil lot, 
1984). However, a significant decrease in total cholesterol was 
observed only when at least 20 gm MaxEPA oil was fed (Sanders & 
Roshani, 1983). 
A study by Sanders and Roshani (1983) fed MaxEPA oil in three 
amounts: 5, 10, and 20 gm/day. Only the 20 gm supplement was 
associated with a decrease in both triglycerides, total cholesterol, 
and an increase in HDL-C; triglycerides responded in a dose response 
manner to the three different levels fed. Saynor et al. (1984) fed 
20 ml supplements for periods of one month to two years and the 
results suggested that the beneficial effects on plasma may be com­
pounded over the two-year period. These findings suggest that to 
observe favorable changes in the lipid bearing fractions, supplemen­
tation must be relatively high (20 gm) and/or for a longer duration 
than has previously been fed. 
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In summary, the human studies reviewed consistently observed a 
lowering of triglycerides associated with n-3 PUFA feeding. Indeed, 
the change in triglycerides associated with consumption of n-3 PUFA 
may be due to a hepatic suppression of VLDL-C formation and catabolism 
to LDL-C, subsequently reducing cholesterol deposition in the tissues 
and arteries (Ballard-Barbash & Calloway, 1987; Herold & Kinsella, 
1986). Other lipid parameters appear to be more resistant in response 
to n-3 PUFAs. For example, total cholesterol requires a relatively 
large dose to observe a clinically significant change. Based on 
findings reported in the studies reviewed, n-3 PUFA may be beneficial 
in reducing triglycerides but may be required in unrealistic amounts 
to affect other lipid parameters. 
Bleeding Time and Prothrombin Time 
Consumption of high amounts of n-3 PUFAs by the Eskimos not 
only resulted in lower plasma lipids but also a favorable change in 
platelet function, which is associated with a decreased risk of CHD. 
Prolonged bleeding time results from a decrease in platelet aggrega­
tion, suggesting that the Eskimos' arteries were protected by some­
thing that alters platelet function (Dyerberg et al., 1982). 
Current research on arachidonic acid (AA) metabolism and its 
role as a precursor for prostaglandins provides a possible mechanism 
for n-3 PUFA action on bleeding time. Figure 1 outlines the scheme 
of LAs conversion to AA and its subsequent conversion to prosta­
glandins. Arachidonic acid is formed from dietary LA by desaturation 
and elongation and by the action of cyclooxygenase to form the 
Linoleic Acid 
desaturase 
Tissue 
Phospholipids 
Linolenic 
eiongase 
ARACHIDONIC 
ACID 
cyclooxygenase Prostanoids 
•»(PGI),RGE,TXA, etc. EPA 
synthestase synthetase 
Endoperoxides 
(PGG9-PGH,) 
thromboxane 
(TXA,) (endothelium) (platelets) 
Prostaglandins 
(PGE,, PGF9, etc.) 
Figure 1. Roles of Linoleic Acid and Arachidonic Acid in Prostaglandin Synthesis. 
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endoperoxides PGG2 and PGH2. These endoperoxides are intermediates 
in prostaglandin synthesis. In the endothelium, the endoperoxides are 
converted to prostacyclin (PGI2) which is a vasodialator and a strong 
inhibitor of platelet aggregation. In platelets the endoperoxides 
are converted to thromboxane A2 (TXA2) which has strong platelet 
aggregating and vasoconstrictive effects. TXA2 has a short half life 
and is quickly converted to TXB2. The balanced antagonistic effect 
of TXA2 and PGI2 regulates the initial step of blood clotting 
(Dyerberg et al, 1982; Herold et al., 1986; Jorgensen & Dyerberg, 
1983; Sanders et al., 1983). 
Increasing dietary n-3 PUFA increases their levels in platelet 
phospholipids, allowing them to compete effectively with AA for 
cyclooxygenase. This alters prostaglandin synthesis patterns and may 
result in a reduction of platelet aggregation and an increased bleed­
ing time (Dyerberg et al., 1982; Jorgensen et al., 1983; Sanders et 
al., 1983). There is also evidence that EPA may be converted to PG13, 
an effective antiaggregatory agent, which accentuates the beneficial 
effects of n-3 PUFA (Jorgensen et al., 1983). 
Rats fed fat-free diets supplemented with alpha-1inolenic (an 
n-3 fatty acid) exhibit a bleeding tendency (Nordoy, Hamlin, Chandler, 
& Newland, 1968) and prostaglandin production is inhibited in rats fed 
linseed oil, which is rich in alpha-1inolenic acid (Ten Hoor, 
de Deckere, Haddeman, Hornstra, & Quadt, 1980). These observations 
can be attributed to the displacement of AA from platelet lipids by 
EPA, which is synthesized from alpha-1inolenic acid (Nordoy et al., 
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1968; Ten Hoor et al., 1980). EPA is a precursor for the trienoic 
prostaglandins. TXA3 is weakly active but PGD3 and prostacyclin PGI3 
are potent inhibitors of platelet aggregation (Needleman, Raz, Minkos, 
Ferrendelli, & Sprecher, 1979). EPA is a more potent inhibitor of 
platelet aggregation in humans than is n-6 PUFA or DHA (Gryglewski, 
Salmon, Ubatuba, Weatherley, Moncada, & Vane, 1979). 
Several human studies have examined the effects of n-3 PUFA on 
bleeding time. Goodnight, Harris, and Connor (1981) observed favor­
able changes in bleeding time when healthy volunteers were fed 454 gm 
(1 lb.) of salmon and 60-90 ml of salmon oil per day. Sanders and 
Roshani (1983) found similar results while feeding MaxEPA oil but 
observed that increased bleeding times were not dose-dependent; that 
is, increasing MaxEPA consumption from 5 gm/day to 20 gm/day did not 
further increase bleeding time. Sanders et al. (1981) observed that 
after only three weeks of supplementation with 20 ml of cod liver 
oil, the subjects' bleeding times were significantly prolonged. 
Bleeding times were also prolonged when males were fed moderate 
amounts (100 gm/day-3 1/2 oz.) of mackerel as compared to meat (100 
gm/day) for six weeks (Houwelingen, Nordoy, van der Beck, Houtsmuller, 
de Metz, & Hornstra, 1987). 
Human subjects were fed 2 gm supplements of EPA/day for 3-6 
weeks (Nagakawa, Orimo, Haragawa, Morita, Yashiro, & Murota, 1983). 
The authors observed a significant decrease in platelet aggregation 
associated with EPA but no significant change in either bleeding time 
or prothrombin time. However, when Saynor et al. (1984) fed 3.6 gm 
EPA/day they observed a significant increase in bleeding time. 
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Very few animal studies have examined n-3 PUFAs effect on bleed­
ing time. Using the rat as the model, Bruckner, Likesh, German, and 
Kinsella (1984) fed diets containing either 1.5% by weight n-3 PUFA-
enriched menhaden oil or 1.09% by weight n-3 PUFA-enriched shark oil. 
Bleeding times of rats fed either n-3-containing diet were not sig­
nificantly different from those of rats fed a control diet. Rats 
consuming a diet that contained 22% by wt. cod liver oil had a 52% 
increase in bleeding time compared to those fed sunflower seed oil 
(Hornstra, Crist-Hazelhof, Haddeman, Ten Hoor, & Nugteren, 1981). 
Due to the different types of fatty fish or fish oils used in 
the studies mentioned above, it is difficult to extrapolate from one 
study to another. However, it is evident that n-3 PUFAs have a pro­
nounced effect on bleeding time in most studies. The effect of pro­
thrombin time has not been frequently studied in association with n-3 
PUFA but, in that it deals directly with blood clotting, will provide 
additional information to the study of n-3 PUFA and CHD. 
Liver Cholesterol 
Type of dietary fat influences cholesterol metabolism and, 
thus, may decrease risk of CHD. It is well established that saturated 
fat is hypercholesterolemic and antherogenic relative to PUFA 
(Jackson, Tavaton, Morrisett, & Gotto, 1978). Several mechanisms for 
the hypocholesterolemic effect of PUFA have been suggested including 
increased cholesterol deposition in body tissues (Jackson et al., 
1978). Although marine oils (n-3 PUFAs) differ in their potential 
for lowering plasma lipids, the mechanism for their action may be 
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similar. The mechanism for the hypolipidemic (primarily triglyc­
erides) action of n-3 PUFA may be due to a hepatic suppression of 
VLDL-C synthesis, but has not been thoroughly researched (Ballard-
Barbash & Calloway, 1987; Herold & Kinsella, 1986). 
A search of the literature did not reveal any studies examin­
ing the effect of n-3 PUFA on liver cholesterol. However, there are 
investigations as to the effects of SFA versus PUFA on this parameter. 
In several studies employing the rat as the model, highly 
unsaturated dietary lipids such as sunflower oil, corn oil, and 
safflower oil were associated with increased hepatic cholesterol con­
tent when compared to lipids high in SFA such as coconut oil or lard 
(Avigan & Steinberg, 1958; Awad, 1981; Bloomfield, 1964; Grunbaum, 
Geary, Grande, Anderson, & Glick, 1957; Klein, 1985; Wiggers, Richard, 
Stewart, Jacobson, & Berger, 1977). Barrows, Heeg, McGilliard, 
Richard, and Jacobson (1980) observed similar results when calves were 
fed beef tallow (SFA source) or soybean oil (PUFA source). The soy­
bean oil contining diet was associated with greater liver choles­
terol. These results suggest that hepatic cholesterol content may be 
influenced by the degree of saturation of the dietary fat; the greater 
the degree of unsaturations being associated with increased liver 
cholesterol. This may be due in part to a shift in cholesterol from 
the plasma to the tissues because of increased catabolism of LDL-C 
(Mayes, 1983). If this is true of n-3 PUFA it may be a partial 
explanation as to the mechanism of their hypolipidemic effects. 
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Ratio of n-6 to n-3 PUFA 
Researchers suggested that there may be a desirable ratio of 
n-6 to n-3 dietary PUFAs (approximately 5) that will facilitate a 
decrease risk of CHD (Budauski & Crawford, 1985). The typical Western 
diet with its preponderance of seed oils may have a ratio of n-6 to 
n-3 PUFAs of greater than 10. 
The n-3 and n-6 families of fatty acids give rise to different 
families of eicosanoids which have differing effects on clotting 
mechanisms (Knapp, Reilly, Alessandrini, & Fitzgerald, 1986; 
Needleman, Raz, Minkes, Ferrendelli, & Sprecher, 1979). However, the 
effect of differing ratios of n-6 to n-3 PUFAs with respect to throm-
bogenic mechanisms (i.e., competition with cyclooxygenase) or plasma 
lipid levels has not yet been researched. 
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CHAPTER III 
METHODOLOGY 
Study Design 
A completely randomized design, utilizing the gerbil as the 
mammalian model, was conducted to assess changes in plasma lipids, 
bleeding time, prothrombin time, and liver cholesterol resulting from 
the feeding of diets containing varying amounts of n-3 and n-6 PUFA. 
This study design allowed evaluation of combinations of n-3 and n-6 
PUFA on the parameter under observation. 
Adult male gerbils (15 per group) were randomly assigned to 
one of six dietary treatment groups. The dietary treatments differed 
only in the type of fat fed; the compositions of the diets are 
describeid in Table 4. All diets contained 15% fat by weight, 15% as 
the test fat, and 1% as safflower oil, a level designed to provide 
essential fatty acid requirements. Group 1 consumed 100% of their 
test fat (14% by weight) as lard (SFA); group 2 , 100% as safflower 
oil (n-6 PUFAO; group 3, 100% as MaxEPA oil (n-3 PUFA); group 4, 25% 
n-3 PUFA and 75% n-6 PUFA; group 5, 25% n-6 PUFA and 75% n-3 PUFA; 
and group 6, 50% n-3 PUFA and 50% n-6 PUFA. 
Food and water were provided ad libitum. The gerbils remained 
on the test diets for five weeks and were weighed weekly. After a 
12-hour fast, the animals were anesthetized using phenobarbital, the 
bleeding time measured, blood collected via exsanguination, and the 
livers removed. 
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Table 4 
Dietary Treatments 
Group Type of Fata 
1 100% saturated fatty acids (lard) 
2 100% safflower oil (n-6 PUFA) 
3 100% MaxEPA oil (n-3 PUFA) 
4 25% MaxEPA and 75% safflower oil 
5 25% safflower oil and 75% MaxEPA 
6 50% MaxEPA and 50% safflower oil 
aAll diets contain 15% fat by weight - 14% as the test fat and 1% 
as safflower oil to meet essential fatty acid requirements. 
Animals 
Male Mongolian gerbils (merionis unguiculatus) weighing 45 +/-
10 gm were purchased from Tumblebrook Farms, West Brookfield, MA. The 
gerbil has been demonstrated to be an appropriate model in the study 
of diet induced hyperlipidemia (Otken & Scott, 1984; Rich, 1968). 
The gerbils were housed in individual solid-bottom cages with 
shredded paper as bedding. Temperature (70°F), humidity, and lighting 
(12-hour alternating dark-light cycle) in the animal room were con­
trolled. 
Diets 
The composition of each of the six test diets is shown in 
Table 5. All diets contained by weight 18% protein as casein and 
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Table 5 
Diet Composition-Recorded as Percent by Weight3 
Ingredient Diet 1 Diet 2 Diet 3 Diet 4 Diet 5 Diet 6 
. . b Casein 18, .0 18, .0 18. .0 18, .0 18, .0 18 .0 
Dextrose 40, .9 40, .9 40. .9 40 .9 40, .9 40 .9 
Cornstarch 15, .0 15, .0 15. 0 15, .0 15, .0 15, .0 
Lard 14, .0 
Safflower Oil 1, .0 15, .0 1. 0 11, .5 4. .5 8, .0 
MaxEPA Oil 14. 0 3, .5 10, .5 7, .0 
Cellulose 5. 0 5. 0 5. 0 5, .0 5, .0 5, .0 
Vitamin Mixc 1. .0 1. .0 1. 0 1. .0 1. .0 1. .0 
Choiine 0. .2 0. .2 0. 2 0. .2 0, .2 0. .2 
Mineral Mix^ 5. ,0 5. ,0 5. 0 5. 0 5. ,0 5. ,0 
Cholesterol 0. ,1 0. ,1 0. 1 0. ,1 0. ,1 0. ,1 
Total Percent 100. ,0 100. ,0 100. 0 100. .0 100. ,0 100. ,0 
a7o calories as fat, 31.4%; carbohydrate, 51.9%; protein 16.7% 
^Vitamin-free test 
cAmerican Institute of Nutrition vitamin mix (addition of choline 
needed) - see Appendix A for composition of vitamin mix 
^American Institute of Nutrition mineral mix - see Appendix A for 
composition of mineral mix 
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55.7% carbohydrate with 40.7% as dextrose and the remaining 15.0% as 
cornstarch. All diets contained 15% fat by weight, 1% as safflower 
oil and the other 14% as a test fat. The diets were isocaloric and 
estimated to provide 31.4% calories as fat, 16.7% as protein, and 
51.9% as carbohydrate. All diets provided a cholesterol (0.1% by 
weight) challenge. The dietary cholesterol was fed to switch the 
majority of plasma cholesterol from the HDL-C fraction to the LDL-C 
fraction. The diets were prepared on site at UNCG using test 
materials purchased from Tecklad Incorporated (Madison, WI) and were 
designed to meet all known nutritional requriements for the gerbil 
(American Institute of Nutrition, 1977). MaxEPA oil was kindly 
donated by R.P. Sherer Corporation. The diets were refrigerated 
throughout the study. 
Blood and Tissue Collection 
The gerbils were fasted for 12 hours, then anesthetized with 
sodium phenobarbital (5 mg/100 gm body wt). Firstly, a bleeding time 
measurement was obtained and secondly, blood samples were collected 
for plasma lipid and prothrombin time analysis from the vena cava 
using 18 gauge hypodermic needles. The blood was centrifuged in glass 
tubes for 15 minutes at 2500 rpm. An aliquot of fresh serum was used 
for prothrombin time and lipoprotein fraction separation. The 
remaining serum was stored in polyethylene vials and frozen at -20°C. 
At sacrifice, the livers were removed, washed in cold saline, and 
frozen at -20°C for future cholesterol analysis. 
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Plasma Lipid Analysis 
Alpha (HDL-C) and beta (LDL-C and VLDL-C) fractions were sepa­
rated by passing fresh serum over heparin-bound agarose columns (Lipo-
Sep, Isolab Inc., Akron, OH). Total cholesterol and the cholesterol 
in the alpha and beta fractions were analyzed by the enzymatic 
colorimetric assay (Isolab Inc., Akron, OH). These cholesterol 
measures (i.e., total cholesterol, alpha fraction, and beta fraction) 
were done on 10 of the 15 gerbils in each dietary treatment group. 
Total triglycerides were measured on the remaining five animals in 
each group using a Sigma diagnostic kit (Sigma Inc., St. Louis, MO). 
Bleeding Time and Prothrombin Time 
While the animals were anesthetized a 2 mm slice was taken from 
the tip of the tail. The incision was blotted every 5-6 seconds. 
Bleeding time was recorded as the number of seconds elapsed between 
the cut and complete clotting (cessation of blood flow). Prothrombin 
time was measured on five gerbils per group and analyzed using an 
assay kit purchased from Sigma Incorporated. 
Liver Cholesterol 
Whole rat livers were homogenized in chloroform/methanol (2/1 
by volume) according to the method of Folch, Leed, and Stanley (1956) 
to obtain liver lipid extracts. The extract was then filtered and 
the filtrate analyzed for cholesterol using the acid method described 
by DeHoff, Davidson, and Kritchevsky (1978). 
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Statistical Analysis 
The general linear model procedure from Statistical Analysis 
System (SAS) was used to fit a fixed-effects linear model to the data; 
this procedure was used to test the overall effect of dietary treat­
ment on the parameters measured in the study. If overall effect was 
statistically significant at the jd .05 level, Tukey's multiple com­
parison test was employed to find which pairs of dietary treatments 
were significantly different. Statistically significant treatment 
effects were found with both weight change and ending weight. The 
statistical analysis of the lipid and blood clotting variables was 
repeated with weight change included as a covariate. The assumption 
of homogeneity of slope was tested and found to hold and the appro­
priately reduced model was fitted. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
The results and discussion of this study are presented i^four 
sections; weight gain in section one, the response of plasma lipids; 
including triglycerides, total cholesterol, and alpha and beta choles­
terol in section two, changes in bleeding time and prothrombin time in 
section three, and lastly, the response of liver cholesterol. Raw 
data for each individual animal are presented in Appendix B. 
Weight Gain 
Means and standard deviations for beginning weight, ending 
weight, and weight change for each dietary treatment are presented in 
Table 6. The sample sizes vary among diets due to the loss of several 
animals prior to the end of the study period. 
Beginning weights were not significantly different among die­
tary treatments (£ = 0.15, £ = 0.98). There were statistically sig­
nificant differences among diets for ending .weight and weight change 
(f = 4.14, £ = 0.0021; F = 4.99, £ = 0.0005, respectively). Tukey's 
multiple comparison test revealed statistically significant differ­
ences (jd < .05) between the 100% n-3 PUFA containing diet and those 
diets containing 100% n-6 PUFA, 25% n-3 PUFA 75% n-6 PUFA, and 50% 
n-6 PUFA 50% n-3 PUFA for both ending weight and weight change. 
The animals consuming the 100% n-3 PUFA containing diet gained 
the smallest amount of weight (5.9 gm). Gerbils fed the other diets 
Table 6 
Means and Standard Deviations for Beginning Weight, Ending Weight, and Weight Change for Each Dietary 
Treatment 
Dietary Treatment 
100 % SFA (n=13) 
100% n-6 PUFA (n=16) 
100% n-3 PUFA (n=15) 
25% n-3 PUFA 75% n-6 PUFA (n=16) 
50% n-3 PUFA 50% n-6 PUFA (n=15) 
75% n-3 PUFA 25% n-6 PUFA (n=15) 
Beginning Weight 
56.4 ± 4.9 
55.1 ± 4.3 
55.5 ± 5.1 
55.5 ± 4.8 
55.9 ± 4.5 
55.1 ± 4.7 
Ending Weight 
gin 
67.7 ± 9.9 
71.8 ± 7.3b 
61.5 ± 7.7a,b'c 
73.5 ± 7.4a 
71.5 ± 9.1C 
68.1 ± 8.6 
Weight Change 
11.3 ± 10.9 
16.6 ± 7.8e 
5.9 ± 4.8d'e,f 
18.0 ± 6.5d 
15.7 ± 8.0f 
13.0 ± 7.5 
a"e means values with alike superscripts are significantly different (p <.05) 
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exhibited weight gains ranging from 11.3 to 18 gms. Those consuming 
the 25% n-3 PUFA 75% n-6 PUFA containing diet gained the most weight; 
however, this was not statistically different from any other treatment 
group with the exception of the 100% n-3 PUFA group. 
One possible explanation for the overall low weight gain of 
the animals may be an infection incurred during the second week of the 
study. Some of the animals (approximately 30%) began having slight 
nose bleeds indicating an upper respiratory infection. The animals 
were then treated with low doses of tetracycline added to the drinking 
water. After one week of treatment the nose bleeds stopped. As the 
infected animals were not confined to one specific diet but randomly 
occurred across all six diets; a link between the dietary treatment 
and the infection was disregarded. However, the low weight gain 
observed in those gerbils consuming the 100% n-3 PUFA containing diet 
may more likely be a consequence of the gerbils expressing an aversion 
to that particular diet. Actual food intake was not measured, but 
weight gain may serve as a proxy. 
The gerbils did not appear to adapt to n-3 PUFA feeding possi­
bly due to its fishy smell and taste. Gerbils consuming diets con­
taining 25, 50, or 75% n-3 PUFA did not appear to have this aversion 
to the diet as indicated by their higher weight gain. The n-6 PUFA 
contained in these diets may have served to mask the fishy smell and 
taste of the n-3 PUFA. As this is the first known research to be con­
ducted investigating n-3 PUFA using the gerbil as the model, there is 
no basis for comparison. However, the gerbil does appear to be 
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sensitive to food components; a study comparing different protein 
sources, reported similar problems of failure to gain weight in 
several aminals consuming one of the protein sources (Forsythe, 1983). 
Plasma Lipids 
The least square means, adjusted for weight change, for tri­
glycerides, total cholesterol, alpha and beta cholesterol, and the 
ratio of the alpha fraction to total cholesterol are presented in 
Table 7. The adjustment for weight change decreased the variability 
about the mean estimate. 
Triglycerides. The only statistically significant effect of 
dietary treatment on any lipid measure was for triglycerides (£ = 
2.87, £ = 0.04). The suggested that 47.5% of the variability in 
triglyceride levels could be accounted for by diet. When Tukey's 
multiple comparison test was employed, the pairs which were signifi­
cantly different (jd <. .05) were 100% n-6 PUFA and 25% n-6 PUFA 75% 
n-3 PUFA, and 100% n-6 PUFA and 50% n-6 PUFA 50% n-3 PUFA. The 
animals consuming the 100% n-6 PUFA containing diet exhibited the 
highest mean triglyceride level (132.1 +/- 14.5 mg/dl). The animals 
fed the 50% n-6 PUFA 50% n-3 PUFA containing diet (54.0 +/- 15.4 mg/ 
dl) and the animals fed the 25% n-6 PUFA 75% n-3 PUFA containing 
diet (67.5 +/- 13.8 mg/dl) exhibited the lowest mean triglyceride 
levels. 
Triglyceride determinations were made on a sub-sample of 
gerbils within each dietary group, sample size ranging from 3 to 5 
animals, therefore, the estimate for total triglycerides may not be 
Table 7 
Least Square Means for Triglycerides, Total Cholesterol, Alpha and Beta Cholesterol, and Alpha to Total 
Cholesterol Ratio for Each Dietary Treatment, Covaried for Weight Change 
Dietary Treatment Triglycerides Total Cholesterol Alpha Beta Alpha/TC 
mg/dl Ratio 
100% SFA 94.1 ± 15.7 
(n=4) 
254.9 ± 22, 
(n=8) 
.1 85.5 ± 7.1 
(n=8) 
133.7 ± 20.9 
(n=8) 
.34 
100% n-6 PUFA 132.1 ± 14.5a,b 
(n=5) 
188.5 ± 25, 
(n=6) 
.6 72.1 ± 6.4 
(n=10) 
138.0 ± 18.7 
(n=10) 
.38 
100% n-3 PUFA 93.2 ± 19.2 
(n=3) 
174.3 ± 37, 
(n=3) 
.8 83.9 ± 7.5 
(n=9) 
118.8 ± 22.0 
(n=9) 
,•48 
25% n-3 PUFA 75% n-6 PUFA 95.5 ± 14.0 
(n=5) 
162.3 ± 25, 
(n=6) 
.5 58.9 ± 6.5 
(n=10) 
82.3 ± 19.1 
(n=l0) 
.36 
50% n-3 PUFA 50% n-6 PUFA 54.0 ± 15.4b 
(n=5) 
196.4 ± 26, 
(n=6) 
.6 68.3 ± 6.9 
(n=9) 
94.5 ± 20.0 
(n=9) 
.35 
75% n-3 PUFA 25% n-6 PUFA 67.5 ± 13.8a 
(n=5) 
182.9 ± 28, 
(n=5) 
.0 74.1 ± 6.7 
(n=9) 
94.7 ± 19.7 
(n=9) 
.41 
a,^Mean values with alike superscripts are significantly different (p< .05) 
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very stable. The high value observed for the 100% n-6 PUFA diet was 
unexpected and not consistent with the literature on the effects of 
dietary fat composition on plasma triglycerides (Glueck, 1979; Stamler, 
1979). In general, polyunsaturated fats lower triglycerides in com­
parison to saturated fats. The unexpected observation of high value 
for the 100% n-6 PUFA group makes it difficult to evaluate the impact 
of the n-3 PUFA containing diets against the n-6 PUFA containing diets. 
Several studies have demonstrated that n-3 PUFA elicit a greater 
lypotriglyceridemic response than n-6 PUFA containing diets. The sig­
nificantly lower triglyceride levels observed in the animals consuming 
diets containing 75% n-3 PUFA and 50% n-3 PUFA is in agreement with 
these studies. Ruiter et al. (1978), who fed pigs diets containing 
either 10% by wt. mackerel oil or 10% by wt. olive oil (monounsaturated 
fatty acid), observed a significant decrease in triglyceride levels 
associated with n-3 PUFA consumption. When Wong et al. (1984) fed rats 
15% by wt. MaxEPA oil or 15% by wt. safflower oil, he too observed a 
significant decrease in triglyceride levels associated with n-3 PUFA 
feeding. 
Morisaki et al. (1983) fed rats 100 mg of EPA or DHA per day 
compared to a basal diet and observed no significant decrease in 
triglyceride levels as a result of n-3 PUFA supplementation. In the 
present study, the 75% n-3 PUFA containing diet contained approximately 
500 mg EPA per day (assuming an average food consumption rate of 5 gm 
per day) and the 50% n-3 PUFA containing diet contains approximately 
350 mg EPA per day. Perhaps concentrations greater than 100 gm per 
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day of EPA may be necessary to observe a significant decrease in tri­
glyceride levels in rodent populations. 
Researchers also observed a decrease in triglyceride levels 
associated with MaxEPA oil feeding in human subjects (Illingworth et 
al., 1984; Nestel, Connor, Reardon, Connor, Wong, & Boston, 1984; 
Sanders & Hochlano, 1983; Sanders & Roshani, 1983). These studies, 
however, used MaxEPA oil as a supplement and not as a substitute for 
other types of fat in the diet. Levels of supplementation as low as 
5 gm MaxEPA oil per day were associated with a significant decrease in 
triglyceride levels (Sanders & Roshani, 1983). 
Although comparison is difficult due to the differences in 
study design and species, another study conducted by Sanders and 
Hochlano (1983) observed a decrease in triglyceride levels associated 
with 10 gm of MaxEPA oil compared to 10 gm corn oil (n-6 PUFA). This 
is similar to the findings of the present study where n-3 PUFA feeding 
was associated with a decrease in triglyceride levels when compared to 
a diet containing n-6 PUFA. 
Total cholesterol. The mean total cholesterol level for the 
animals consuming the 25% n-3 PUFA 75% n-6 PUFA containing diet 
(174.3 +/- 37.8 mg/dl) was the lowest of the six dietary treatment 
while the animals fed the 100% SFA containing diet exhibited the 
highest mean total cholesterol level (254.9 +/- 22.1 mg/dl). However, 
these differences did not reach statistical significance. Saturated 
fatty acid containing diets are typically hypercholesteroleic as com­
pared to PUFA containing diets (Keys, Anderson, & Grande, 1957). The 
34 
animals consuming the five diets containing different combinations of 
n-3 and n-6 PUFA exhibited similar total cholesterol levels as they 
were all 100% PUFA. There was no apparent effect of feeding n-3 PUFA 
as compared to n-6 PUFA with respect to total cholesterol. 
A study conducted by Kobatake, Hirahara, Innami, and Nishiole 
(1983) observed a significant decrease in total cholesterol levels when 
rats were fed 5% squid liver oil (n-3 PUFA) compared to 5% lard (SFA). 
Although the results did not reach statistical significance, the 
animals consuming the n-3 PUFA containing diets did exhibit lower total 
cholesterol levels than those consuming the 100% SFA containing diet. 
When Wong, Nestel, Trimble, Storere, Illman, and Topping (1984) com­
pared MaxEPA oil and safflower oil in the rat (fed at a level consis­
tent with the present study - 15% by wt.) there were no significant 
differences in total cholesterol levels. This is similar to the 
findings in the current study that n-3 PUFA have no significant effect 
on total cholesterol levels when compared to n-6 PUFA. 
Two other studies employing the rat as a model also observed 
no significant change in total cholesterol when 100 mg of EPA per day 
was fed in comparison to a basal diet (Morisaki et al., 1983). Ruiter 
et al. (1978) alos observed no significant decrease in total choles­
terol levels associated with feedinq piqs a 10% mackerel oil diet as 
compared to a 10% olive oil diet. 
Human feeding trials have shown conflicting results with respect 
to the effect of n-3 PUFA on total cholesterol levels. Studies 
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consistent with the findings observed in the present study are as 
follows. When von Lossonczy et al. (1978) compared cheese (SFA) to 
mackerel (n-3 PUFA), a significant decrease in total cholesterol was 
associated with n-3 PUFA consumption. A study conducted by Sanders and 
Roshani (1983) observed no effect on total cholesterol when n-3 PUFA 
(MaxEPA oil) was compared to n-6 PUFA (corn oil). 
Research,by Singer, Jaeger, Wirth, Voigt, Nauman, Zimontkowski, 
Hajdu, and Goedicke (1983) contradicts the findings of the above 
reported studies. Subjects consumed either 280 gm per day of herring 
or 280 gm per day of mackerel. Although the predominant fatty acids 
in both fish are PUFA, there was a significant decrease in total 
cholesterol levels associated with consumption of mackerel (n-3 PUFA). 
Possibly a factor other than the n-3 PUFA in the fish caused the 
decrease in total cholesterol. 
In summary, n-3 PUFA may exhibit a hypocholesterolemic effect 
when compared to SFA but this decrease is not significantly greater 
than that observed with n-6 PUFA feeding. The predominant PUFA in the 
American diet is n-6 PUFA, and may be a more feasible hypocholestero­
lemic agent than n-3 PUFA for the general population. 
Alpha fraction. The alpha fraction measured in the present 
study represents the HDL-C level. There were no significant differ­
ences among the dietary treatments with respect to HDL-C levels; 
however, a trend was observed in the HDL-C data. The highest HDL-C 
level was observed in the animals consuming the 100% SFA containing 
diet. The animals consuming the 100% n-3 PUFA containing diet 
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exhibited the second highest HDL-C level. This observation is consis­
tent with the findings of Sanders and Hochlano (1983) who observed an 
increase in HDL-C levels when humans were fed 10 gm of MaxEPA oil com­
pared to 10 gm olive or corn oil. Studies by Sanders and Roshani 
(1983) and Saynor, Verel, and Gillott (1984) also observed an increase 
in HDL-C when the diets of human subjects were supplemented with 20 gm 
MaxEPA oil per day. Other studies using normolipidemic subjects found 
no significant differences in HDL-C levels when n-3 PUFA were fed 
(Bronsgeest et al., 1981; Fehily et al, 1983; Harris et al., 1983; 
Singer et al., 1983). 
* 
Animal studies employing the rat as a model also found conflict­
ing results with respect to n-3 PUFA consumption and HDL-C levels. 
Kobatake et al. (1983) observed a significant increase in HDL-C levels 
when n-3 PUFA feeding was compared to SFA feeding. Another study in 
the rat conducted by Morisaki et al. (1983) found no significant change 
in HDL-C when EPA was fed but a significant increase in HDL-C when DHA 
was fed. The predominant n-3 PUFA fed in the present study was EPA; 
this may provide a partial explanation for the nonsignificant findings 
for HDL-C in the present study. 
The findings with respect to HDL-C levels and n-3 PUFA feeding 
are clearly inconsistent. However, accumulation of data to date, 
suggest that even though n-3 PUFA may not significantly decrease total 
cholesterol they may favorably change the way cholesterol is carried in 
the plasma. 
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One measure of the atherogenecity of a diet is the HDL-C (alpha) 
to total cholesterol ratio; higher ratios being more desirable. 
Although there was no statistical difference among diets, the trend was 
as expected with the animals consuming the 100% SFA containing diet 
exhibiting the lowest ratio and the animals fed the n-3 PUFA and n-6 
PUFA containing diets exhibiting higher ratios. 
Beta fraction. There was no significant effect of dietary 
treatment on the beta fraction, however, the response to the different 
diets was greater and more variable in the beta fraction than was 
observed in the alpha fraction. The beta fraction is composed of both 
the LDL-C and VLDL-C lipoproteins but the VLDL-C fraction is the major 
carrier for triglycerides. The significant differences in triglyceride 
levels in three of the dietary treatments might suggest an expected 
difference in VLDL-C levels since VLDL-C is carrying primarily tri­
glyceride. However, if there was a decrease in VLDL-C associated with 
the dietary treatments it was not large enough to be detected in the 
total beta fraction. 
Few studies have measured either LDL-C or VLDL-C. Ruiter et al. 
(.1978) observed a significant decrease in VLDL-C in pigs fed 10% 
mackerel oil compared to 10% olive oil. The decrease in VLDL-C was 
in conjunction with a significant decrease in triglyceride levels. 
This VLDL-C level was, however, not measured chemically but by using a 
formula, which is not consistent with the means of measurement of the 
present study. Morisake et al (1983) observed no change in LDL-C or 
VLDL-C levels when rats were fed 100 gm of EPA per day. This study 
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also observed no change in total cholesterol levels. These findings 
are consistent with the nonsignificant findings with respect to the 
beta fraction of the current study (i.e., nonsignificant differences 
in total cholesterol and the beta fraction). Human studies measuring 
LDL-C and/or VLDL-C that observed no significant change in total 
cholesterol also observed no significant change in LDL-C or VLDL-C 
associated with n-3 PUFA feeding (Bronsgeest et al., 1981; Fehily et 
al., 1983). 
Bleeding Time and Prothrombin Time 
Means for bleeding time and prothrombin time for each dietary 
treatment, adjusted for weight change, are presented in Table 8. No 
overall effect of dietary treatment on bleeding time or prothrombin 
time (£ = 1.94, £= 0.086; £= 0.85, jp = 0.55, respectively) was 
observed. 
Omega-3 PUFA have been shown to effect prostaglandin production 
in a way that favorably alters platelet aggregation and increases 
bleeding time (Dyerberg et al., 1932; Herold et al., 1986; Jorgensen & 
Dyerberg, 1983; Sanders & Hochlano, 1983). The present study was 
designed to assess the level of n-3 PUFA associated with a favorable 
change in bleeding time. However, there were no significant differ­
ences across the six dietary treatments with respect to bleeding time 
nor was any trend in the data observed. Unexpectedly, the gerbils fed 
the 100% n-3 PUFA containing diet exhibited the lowest bleeding time. 
This is in disagreement with studies conducted in both humans and 
other animal models. 
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Table 8 
Least Square Means for Bleeding Time and Prothrombin Time for Each 
Dietary Treatment, Covaried for Weight Change 
Dietary Treatment Bleeding Time3 Prothrombin Time'3 
100% SFA 3, .04 + 0.43 (n=12) 19 .64 + 2.38 (n=4) 
100% n-6 PUFA 2, .98 + 0.42 (n=13) 21 .16 + 2.19 (n=5) 
100% n-3 PUFA 2, .20 + 0.49 (n=ll) 17 .06 2.92 (n=3) 
25% n-3 PUFA 75% n-6 PUFA 2. .87 + 0.39 (n=16) 21 .39 + 2.12 (n=5) 
50% n-3 PUFA 50% n-6 PUFA 4. .02 + 0.43 (n=12) 17 .74 + 2.71 (n=4) 
75% n-3 PUFA 25% n-6 PUFA 2. .78 + 0.39 (n=15) 23 .56 ± 2.09 (n=5) 
arecorded in minutes and fractions of minutes 
^recorded in minutes 
Human studies consistently observed significant increases in 
bleeding time associated with n-3 PUFA consumption. Goodnight et al. 
CI981) fed 1 lb of salmon and 60-90 ml salmon oil per day and observed 
a significant increase in bleeding time. Two studies feeding fish oil 
also observed a significant increase in bleeding time (Sanders & 
Roshani, 1983; Sanders et al., 1981). Feeding even moderate amounts of 
fatty fish (100 gm per day) produced significant prolonged bleeding 
times in healthy males (Houwelingen, Nordoy, van der Beek, Houtsmuller, 
de Metz, & Hornstra, 1987). 
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Rats fed a diet with 45% of the total calories from cod liver 
oil exhibited a significant increase in bleeding time (Hornstra et al., 
1981). Another study feeding fish oil observed no effect of n-3 PUFA 
on leeding time (Bruckner et al., 1984). However, the level fed was 
very low (1.5% by wt.) compared to the level fed in the present study 
(3.5 - 14.0% by wt.). 
A possible reason for the disagreement in the results of this 
study and those reviewed may be due to the methodology used to measure 
the bleeding time. The method used in rats of exposing the major 
artery in the leg, cutting the artery and measuring clotting time, 
was not feasible due to the small size of the gerbil. Alternate ways 
were pilot tested, the most successful being cutting the tail at 2 mm 
and timing the clotting of the cut. In preliminary tests, this method 
appeared to be the most reliable in providing adequate blood flow. In 
order to reduce any experimental bias, both the person timing and the 
person determining the point of clotting were blinded to the dietary 
treatment. Difficulty was encountered in consistently cutting at 
exactly the same point on the tail; this may have introduced measure­
ment variability. Possibly cutting a longer segment of the tail than 
2 mm would provide a more precise measure of bleeding time. However, 
this might compromise collection of a maximum volume of blood for 
other analyses due to excessive blood loss from the bleeding time pro­
cedure. 
Bleeding time reflects the effectiveness of the platelet plug 
formation at site of vascular injury. Prothrombin time is a test of 
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the extrinsic pathway and also the final common pathway of clotting, 
the latter involves the activity of thrombin. Thrombin is actively 
controlled via two mechanisms; one is the existence of a thrombin 
antagonist antithrombin III, the other involves the inactive thrombin 
zymogen prothrombin. Plasma levels of antithrombin III have been 
demonstrated to increase on feeding 10 gm supplements of either fish 
or vegetable oil (Mortensen, Schmidt, Nielsen, & Dyerberg, 1983). 
Thus, suggesting that no only platelet function but also fibrin clot 
formation may be altered by n-3 PUFA feeding. 
These findings are in disagreement with the present study which 
observed no significant effects of dietary treatment on prothrombin 
time. However, a study conducted by Nagakawa, Orimo, Harasawa, Morita, 
Kashirok, and Murota (1983) also observed no change in prothrombin 
time when human subjects were fed 2 gm EPA/day. Due to conflicting 
results in the relatively few studies measuring the effects of n-3 PUFA 
on prothrombin time, the degree to which n-3 PUFA alter prothrombin 
time is yet to be fully understood. 
Liver Cholesterol 
Means for liver cholesterol for each dietary treatment, adjusted 
for weight change, are presented in Table 9. There was no overall 
effect of dietary treatment on liver cholesterol (£_ = 1.91, £ = 
0.089). Although it did not reach statistical significance, the 
animals fed the 100% n-3 PUFA containing diet exhibited the lowest 
liver cholesterol level (19.67 +/- 2.31 mg/gm). The other polyun­
saturated fat containing diets consistently showed higher liver 
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cholesterol levels, greater than that seen with the SFA containing 
diet. The literature reports that SFA consumption is associated with 
lower hepatic cholesterol when compared to PUFA consumption (Avigan & 
Steinberg, 1958; Awad, 1981; Barrows et al., 1980; Bloomfield, 1964; 
Grunbaum et al., 1957; Klein, 1958; VJiggers et al., 1977). 
Table 9 
Least Square Means for Liver Cholesterol for Each Dietary Treatment, 
Covaried for Weight Change 
Dietary Treatment Liver Cholesterol 
mg/dl 
20.89 ± 2.31 (n=13) 
22.64 ± 2.10 (n=16) 
19.67 ± 2.31 (n=15) 
22.57 ± 2.13 (n=16) 
23.81 ± 1.11 (n=l5) 
21.01 ± 2.14 (n=15) 
100% SFA 
100% n-6 PUFA 
100% n-3 PUFA 
25% n-3 PUFA 75% n-6 PUFA 
50% n-3 PUFA 50% n-6 PUFA 
75% n-3 PUFA 25% n-6 PUFA 
If the 100% n-3 PUFA containing diet is eliminated from the 
analysis, the other four diets that contain all PUFA had very similar 
liver cholesterol levels. This suggests that n-6 PUFA and n-3 PUFA 
may have similar effects on liver cholesterol. Increased deposition 
of cholesterol in tissue is a proposed mechanism for the hypocho-
lesterolemic action of PUFA (Jackson et al, 1978). 
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Concluding Comments 
Two objectives of the study were to assess the effect of differ­
ing levels of n-3 and n-6 PUFA fed in combination and the effects of 
n-3 PUFA, n-6 PUFA, and SFA on plasma lipids, bleeding time, prothrom­
bin time, and liver cholesterol. The dietary treatments had no sig­
nificant effects on any parameter measured with the exception of 
plasma triglycerides. The gerbils consuming the 100% n-6 PUFA 
exhibited significantly (£-si.05) lower triglyceride levels than those 
animals consuming the 50% n-6 PUFA 50% n-3 PUFA and the 75% n-3 PUFA 
25% n-6 PUFA containing diets. 
Another objective of the present study was to determine at what 
combination of n-3 and n-6 PUFA there was a hypolipidemic effect with­
out compromising the beneficial reduction in platelet adhesiveness, 
as measured by bleeding time. As mentioned above, the only signifi­
cant effect on plasma lipids was observed in triglycerides. The 50% 
n-6 PUFA 50% n-3 PUFA containing diet exhibited the lowest tri­
glyceride levels. As there were no significant changes in any other 
plasma lipid parameter, nor any significant changes or trends in the 
bleeding time data, it is not possible to suggest a ratio of n-3 to 
n-6 PUFA that would favorably effect plasma lipids and bleeding time 
simultaneously. 
A final objective was to determine the usefulness of the gerbil 
as a model in the study of diet and CHD risk factors. Several prob­
lems were encountered in using the gerbil, including infection; 
aversion to the 100% n-3 PUFA diet; low weight gain; and low blood 
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volume available for analysis. However, the fact remains that the 
gerbil is a more suitable model than the rat for the study of lipid 
metabolism due to the way the gerbil carries cholesterol in plasma 
(closely resembles humans when challenged with dietary cholesterol). 
If the limitations of using the gerbil are addressed by the study 
design (i.e., increased animal numbers to increase total blood col­
lected, sterile environment, etc.), the gerbil could be an acceptable 
model to assess effect of diet on chronic disease risk factors. 
Hypothesis Tests 
Hypothesis 1 stating that there will be no significant differ­
ence in plasma triglycerides across the six dietary treatments was 
rejected. 
Hypothesis 2 stating that there will be no significant differ­
ence in total cholesterol across the six dietary treatments was 
accapted. 
Hypothesis 3 stating that there will be no significant differ­
ence in HDL cholesterol across the six dietary treatments was accepted. 
Hypothesis 4 stating that there will be no significant differ­
ence in LDL and VLDL cholesterol across the six dietary treatments was 
accepted. 
Hypothesis 5 stating that there will be no significant differ­
ence in bleeding time across the six dietary treatments was accepted. 
Hypothesis 6 stating that there will be no significant differ­
ence in prothrombin time across the six dietary treatments was 
accepted. 
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Hypothesis 7 stating that there will be no significant differ­
ence in liver cholesterol across the six dietary treatments was 
accepted. 
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CHAPTER V 
RECOMMENDATIONS FOR FUTURE RESEARCH 
Currently research concerning n-3 PUFA have concentrated on the 
risk factors of plasma lipids and platelet function. Research is 
needed in several areas related to n-3 PUFA. Few studies have been 
conducted in animals other than rodents. The pig or primate would be 
appropriate models to explore n-3 PUFA mechanisms of action on bleed­
ing time and plasma lipids as they more closely resemble humans in 
physiology. These models could also be employed to assess the effects 
on n-3 PUFA when fed in varying combinations with n-6 PUFA to ascer­
tain an optimal ratio for decreasing risk factors of CHD. Using 
repeated measures would allow the researcher to assess the effects of 
n-3 PUFA feeding and a combination of n-3 and n-6 PUFA feedings on 
bleeding time and plasma lipids over the course of time. 
Research efforts are also needed to assess the effects of n-3 
PUFA at the cellular level. Cyclooxygenase acts on AA to form 
endoperoxides, which are intermediate compounds in the synthesis of 
the prostaglandins known to have strong platelet aggregating and vaso-
constricting effects (Dyerberg et al., 1982; Herold et al., 1986; 
Jorgensen & Dyerberg, 1983; Sanders et al., 1983). Studies measuring 
the effect of n-3 PUFA fed in combination with varying levels of n-6 
PUFA on the AA synthesis pathway enzymes and tissue levels of AA would 
provide information on levels of n-3 PUFA required to favorably alter 
prostaglandin synthesis and may partially explain mechanisms involved. 
Evidence indicates that n-3 PUFA may decrease the risk of CHD 
because of their possible effects on monocytes. Monocytes adhere to 
the artery wall in atherosclerosis and are then transformed into 
macrophages, which accumulate lipid material from circulating lipo­
proteins (Ross, Bowen-Pope, Raines, & Faggiotto, 1982). Fish oil 
feeding may increase the EPA content in the membrane of monocytes and 
favorably alter leukotriene production (i.e., increase B5 and decrease 
B4 leukotrienes) which could decrease adherence of the monocyte to the 
artery wall (Lands, 1986). Research is needed to determine the possi­
bility of this mechanism and how n-6 PUFA may compete with n-3 PUFA for 
lipoxygenase, an enzyme in the leukotriene production pathway. 
Additional research is needed in the area of fish oil supplemen­
tation (i.e., fish oil capsules) in order to ascertain both beneficial 
qualities and possible long-term side effects. Comparison studies 
examining consumption of fish oil capsules versus fatty fish on plasma 
lipids and platelet function would prove helpful to isolate which com­
ponent of fatty fish is associated with favorable changes in CHD risk 
factors. 
It is not feasible for Americans to consume the amounts of 
fatty fish ingested by Eskimo populations, as they consume upwards of 
1 lb. of fatty fish per day (whale blubber and other marine oils). 
The average per capita consumption of fish in the United States is 
less than 1 oz. per day, and this is primarily fish which contributes 
little n-3 PUFA (Dyerberg, 1986). Thus, data are needed in the areas 
of long-term consumption of low levels of fatty fish and 
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supplementation with n-3 PUFA in order to assess the likelihood of 
using n-3 PUFA as a preventive measure for CHD. Such research would 
provide useful information to health professionals so that they may 
suggest appropriate recommendations to the American population with 
regard to n-3 PUFA. 
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APPENDIX A 
COMPOSITION OF AMERICAN INSTITUTE OF NUTRITION 
VITAMIN AND MINERAL MIX 
57 
American Institute of Nutrition Vitamin Mix 
(AIN-76A #40077) Composition 
Ingredient gm/Kg 
Thiamine HC1 0.6 
Riboflavin 0.6 
Pyridoxine HC1 0.7 
Niacin 3.0 
Calcium Pantothenate 1.6 
Folic Acid 0.2 
Biotin 0.02 
Vitamin B-12 (0.1% trituration in mannitol) 1.0 
Dry Vitamin A Palmitate (500,000 U/gm) 0.8 
Dry Vitamin A Acetate (500 U/gm) 10.0 
Vitamin D-3 trituration (400,000 U/gm) 0.25 
Menadione Sodium Bisulfite Complex 0.15 
Sucrose, Fine Powder 981.08 
58 
American Institute of Nutrition Mineral Mix 
(AIN-76) Composition 
Ingredient 
Calcium 
Phosphorus 
Potassium 
Sodium 
Chlorine 
Sulfur 
Iodine 
Iron 
Magnesium 
Zinc 
Copper 
Manganese 
Selenium 
Chromium 
Sucrose 
gm/Kg 
5.1551 
3.9840 
3.6023 
1.0188 
1.5711 
.3374 
.0002 
.0351 
.5067 
.0314 
.0056 
.0585 
.0001 
.0020 
4.13105 
APPENDIX B 
RAW DATA 
29 
81 
41 
99 
71 
47 
19 
74 
56 
25 
17 
9 
60 
48 
43 
70 
30 
24 
5 
51 
10 
1 
23 
91 
72 
100 
80 
36 
11 
64 
38 
45 
68 
83 
92 
52 
53 
et 
Beginning 
Weight 
(gm) 
Ending 
Weight 
(gm) 
Bleeding 
Timea 
Liver 
Cholesterol Triglycerides'" 
Prothrombin 
Timed 
Total 
Cholesterol Alpha0 Betac 
Weight 
Change 
(gm) 
47 78 0.91 17.28 103.8 17.0 0.0 0.0 0.0 21 
55 82 1.96 15.74 0.0 0.0 0.0 70.1 57.1 27 
52 77 2.88 37.68 0.0 0.0 0.0 73.1 65.8 25 
54 72 3.65 29.09 48.6 24.5 0.0 0.0 0.0 18 
54 67 2.36 17.06 115.5 19.0 0.0 0.0 0.0 13 
56 79 4.16 26.72 69.9 21.0 0.0 0.0 0.0 23 
58 62 1.51 16.93 0.0 0.0 167.2 84.1 81.1 4 
53 81 2.66 9.29 0.0 0.0 0.0 35.5 30.5 28 
47 62 2.18 24.24 0.0 0.0 169.3 61.9 119.0 15 
65 75 2.35 19.21 134.1 25.0 0.0 0.0 0.0 10 
57 69 3.49 13.41 0.0 0.0 119.0 46.3 71.4 12 
53 73 5.53 34.50 0.0 0.0 0.0 0.0 0.0 20 
63 86 4.94 25.14 0.0 0.0 123.5 64.2 53.5 23 
61 78 3.16 26.69 0.0 0.0 272.1 92.0 169.2 17 
48 63 1.70 31.94 0.0 0.0 0.0 57.1 80.1 15 
55 72 3.83 34.12 0.0 0.0 121.6 37.6 68.8 17 
6 57 73 5.15 0.0 52.5 14.5 0.0 0.0 0.0 16 
6 64 64 1.05 23.55 0.0 0.0 144.4 62.6 69.1 0 
6 57 82 8.62 21.34 0.0 0.0 232.7 87.1 121.5 25 
6 58 83 2.33 27.10 0.0 0.0 132.1 63.6 59.0 25 
6 63 85 2.99 18.76 0.0 0.0 183.7 69.0 74.0 22 
6 0 0 0.00 18.41 130.6 17.0 0.0 0.0 0.0 0 
6 52 77 3.10 31.41 59.9 22.0 0.0 0.0 0.0 25 
6 53 65 5.12 16.09 0.0 0.0 0.0 0.0 0.0 12 
6 47 61 1.46 42.24 0.0 0.0 0.0 75.2 97.2 14 
6 55 76 3.94 20.69 0.0 0.0 318.3 95.7 197.7 21 
6 61 81 0.00 26.00 0.0 0.0 0.0 51.0 25.2 20 
6 53 75 0.00 24.40 0.0 0.0 153.3 80.2 61.2 22 
6 55 64 8.88 14.34 60.8 16.5 0.0 0.0 0.0 9 
6 56 65 3.15 20.08 41.7 0.0 0.0 0.0 0.0 9 
6 52 56 0.00 22.06 0.0 0.0 0.0 0.9 0.0 4 
6 55 66 2.87 32.64 0.0 0.0 0.0 55.5 114.9 11 
3 58 61 1.50 11.55 0.0 0.0 203.9 68.0 151.5 3 
3 48 53 0.93 20.44 0.0 0.0 166.8 52.7 86.5 5 
3 52 52 1.16 13.33 63.0 14.5 0.0 0.0 0.0 0 
3 53 56 2.90 8.74 0.0 0.0 0.0 53.8 58.7 3 
3 52 62 0.00 28.59 0.0 0.0 0.0 0.0 0.0 10 
3 56 70 2.01 20.62 0.0 0.0 0.0 77.1 106.1 14 
3 55 56 0.92 9.65 0.0 0.0 0.0 0.0 0.0 1 
3 55 61 3.76 21.47 0.0 0.0 0.0 88.0 249.9 6 
3 66 72 1.45 19.17 126.8 20.5 0.0 0.0 0.0 6 
3 61 70 0.00 35.40 99.4 17.0 0.0 0.0 0.0 9 
3 
3 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
5 
1 
1 
1 
1 
1 
1 
1 
3 
11 
8 
4 
2 
17 
20 
19 
9 
27 
20 
24 
12 
1 
21 
13 
25 
14 
19 
20 
20 
16 
10 
5 
23 
6 
16 
2 
9 
23 
20 
9 
1 
15 
20 
7 
18 
3 
23 
15 
- 1 
Beginning Ending 
Weight Weight Bleeding Liver Prothrombin Total 
(gin) (gm) Time3 Cholesterol Triglycerides Timed Cholesterol Alpha Beta 
63 75 3.42 14.46 0.0 0.0 163.0 67.1 69.0 
55 52 0.00 10.59 0.0 0.0 0.0 73.2 135.9 
56 67 2.53 27.39 0.0 0.0 0.0 97.4 99.1 
47 55 0.00 15.14 0.0 0.0 0.0 0.0 0.0 
56 60 1.80 10.03 0.0 0.0 0.0 110.9 166.4 
55 57 2.70 18.11 0.0 0.0 192.4 42.2 142.7 
53 73 2.48 31.85 0.0 0.0 243.3 78.5 132.4 
53 73 0.00 8.02 158.0 22.0 0.0 0.0 0.0 
59 78 1.98 21.03 109.0 16.5 0.0 0.0 0.0 
58 67 1.90 18.61 84.2 21.5 0.0 0.0 0.0 
48 75 2.88 25.52 0.0 0.0 0.0 89.6 268.7 
53 73 3.52 15.50 0.0 0.9 118.2 67.7 41.4 
47 71 1.94 44.17 114.2 21.5 0.0 0.0 0.0 
55 67 0.00 19.60 0.0 0.0 0.0 0.0 0.0 
56 55 1.69 11.19 0.0 0.0 243.4 53.8 131.6 
52 73 3.75 12.20 0.0 0.0 122.6 57.7 52.0 
63 81 4.69 27.50 0.0 0.0 214.9 73.6 143.3 
56 81 0.00 29.39 185.3 23.5 0.0 0.0 0.0 
62 76 4.06 33.02 0.0 0.0 0.0 122.9 236.3 
54 73 6.45 34.57 0.0 0.0 0.0 63.2 122.9 
54 74 1.19 24.39 0.0 0.0 0.0 82.1 100.9 
56 76 1.86 23.09 0.0 0.0 166.5 65.9 73.4 
58 74 2.98 20.17 0.0 0.0 0.0 97.5 155.2 
65 75 3.86 19.85 0.0 0.0 0.0 53.5 48.3 
53 58 4.75 20.90 0.0 0.0 98.6 47.6 45.3 
48 71 4.54 9.93 31.7 26.0 0.0 0.0 0.0 
52 58 2.16 16.00 0.0 0.0 203.6 65.5 94.7 
57 73 2.54 13.14 0.0 0.0 0.0 117.7 145.9 
53 55 1.05 27.99 110.3 32.5 0.0 0.0 0.0 
47 56 3.39 24.32 64.7 27.5 0.0 0.0 0.0 
52 75 0.77 23.99 0.0 0.0 227.4 99.5 108.0 
54 74 2.96 13.40 75.1 16.5 0.0 0.0 0.0 
56 65 2.64 22.65 57.7 15.5 0.0 0.0 0.0 
59 60 3.16 24.31 0.0 0.0 0.0 0.0 0.0 
55 70 1.73 39.05 0.0 0.0 219.3 53.8 144.5 
61 81 3.01 14.43 0.0 0.0 0.0 65.8 36.7 
54 61 2.15 33.56 0.0 0.0 210.6 47.0 145.6 
57 75 5.05 12.32 0.0 0.0 167.9 83.1 75.6 
54 57 3.63 16.21 0.0 0.0 319.6 93.4 114.8 
58 81 2.05 21.52 0.0 0.0 301.5 128.4 155.2 
61 76 1.29 29.01 0.0 0.0 . 205.3 85.3 84.0 
64 63 3.55 4.44 80.7 15.0 0.0 0.0 0.0 
65 56 0.00 7.28 0.0 0.0 0.0 0.0 0.0 
Beginning Ending Weight 
Animal Weight Weight Bleeding Liver Prothrombin Total _ Change 
Number Diet (gm) (gm) Time3 Cholesterol Triglycerides Time" Cholesterol Alpha Beta (gin) 
7 1 53 74 4.94 22.02 0.0 0.0 245.7 88.5 92.4 21 
78 1 47 62 2.70 33.22 86.4 18.0 0.0 0.0 0.0 15 
97 1 55 83 1.26 16.59 90.3 21.5 0.0 0.0 0.0 28 
35 1 53 64 2.87 15.15 0.0 0.0 378.2 58.4 317.2 11 
20 1 55 54 3.61 20.17 124.1 24.5 0.0 0.0 0.0 -  1 
6 1 57 74 3.20 32.85 0.0 0.0 210.0 98.6 86.0 17 
Measured in minutes and fractions of minutes 
^mg/gm 
cmg/dl 
^Seconds 
